- JAMA Study: "Although prices are often justified by the high cost of drug development, there is no evidence of an association between research and development costs and prices; rather, prescription drugs are priced in the United States primarily on the basis of what the market will bear." http://www.fiercepharma.com/pharma/patent-schemes-hostage-government-payers-driving-u-s-drug-spending-report-says?utm_medium=nl&utm_source=internal&mrkid=1000019&mkt_tok=eyjpijoitnpbee4ytmlnelu0tkdfmyisinqioijwqkdcylq4vlzmmlh2mljwc241vgywy2ncl3rzynb6zkdlu0lnnlm5njq1dw5mzezhammxew9tnja1dm53azvksguyshdcl2ffv1m3b3orotnytctssvwvvg5wnw1ocxhkadnamvuwwfr1nwzsaz0ifq%3D%3D 56 comments science
Linked pages
Related searches:
Search whole site: site:www.fiercepharma.com
Search title: Patent schemes, hostage government payers driving U.S. drug spending, report says | Fierce Pharma
See how to search.